Transverse myelitis: Difference between revisions

From IDWiki
(Imported from text file)
 
Line 1: Line 1:
−
== Definition ==
+
==Definition==
   
−
* Heterogeneous condition characterized by inflammation of the spinal cord
+
*Heterogeneous condition characterized by inflammation of the spinal cord
   
−
== Etiology ==
+
==Etiology==
   
  +
*CNS disorders
−
* Post-infectious
 
  +
**[[Multiple sclerosis]]
−
* Post vaccination
 
  +
**[[Neuromyelitis optica]]
* Infectious
 
  +
**[[Acute disseminated encephalomyelitis]] (ADEM)
−
** VZV
 
  +
**[[Myelin oligodendrocyte glyocprotein antibody-associated disorder]]
−
** CMV
 
 
*Systemic inflammatory disorders
−
** Etc.
 
 
**[[Sarcoidosis]]
* Systemic inflammatory conditions
 
  +
**[[Sjögren syndrome]]
** Sarcoidosis
 
  +
**[[Systemic lupus erythematosus]]
−
* Acquired demyelinating disease
 
  +
**Others: [[ankylosing spondylitis]], [[antiphospholipid antibody syndrome]], [[Behçet disease]], [[mixed connective tissue disease]], [[rheumatoid arthritis]], and [[systemic sclerosis]]
−
** MS
 
 
*Infectious
* Idiopathic
 
  +
**[[Enteroviruses]], especially D68 and EV71
  +
**[[West Nile virus]]
  +
**[[Herpesviridae]], including [[HSV]], [[VZV]], [[EBV]], [[CMV]], and [[HHV-6]]
  +
**[[HIV]]
  +
**[[HTLV-1]]
  +
**[[Zika virus]]
  +
**[[Lyme disease]]
  +
**[[Mycoplasma species]]
  +
**[[Treponema pallidum]]
  +
*Paraneoplastic, most often secondary to [[small cell lung cancer]]
  +
**Anti-Hu disease
  +
**Anti-CRMP5 disease
 
*Idiopathic
   
−
== Clinical Presentation ==
+
==Clinical Manifestations==
   
  +
*Presentation is either acute or subacute, usually starting with sensory changes, weakness, or pain
−
* Motor and sensory deficits
 
  +
*Characterized by both motor and sensory deficits, with specific deficits depending on the spinal level of the lesion
   
−
== Investigations ==
+
==Investigations==
   
−
* MRI spine '''with gadolinium'''
+
*MRI spine '''with gadolinium''', showing characteristic T2 hyperintensity without evidence of cord compression
  +
*CSF showing pleocytosis
   
−
== Diagnosis ==
+
==Diagnosis==
   
−
* Bilateral sensorimotor and autonomic spinal cord dysfunction
+
*Sensorimotor and autonomic spinal cord dysfunction
−
** May be asymmetric
+
**Generally bilateral but may be asymmetric
−
* Clearly defined sensory level
+
*Clearly defined sensory level
  +
*Bilateral signs and symptoms
−
* Progression peaking between 4h and 21d after onset
+
*Progression peaking between 4h and 21d after onset
−
* Demonstration of spinal cord inflammation
+
*Demonstration of spinal cord inflammation
−
** Cerebrospinal fluid with pleocytosis or increased IGG
+
**Cerebrospinal fluid with pleocytosis or increased IGG
−
** MRI with gadolinium
+
**MRI with gadolinium
−
* Exclusion of compressive, postradiation, neoplastic, and vascular causes
+
*Exclusion of compressive, postradiation, neoplastic, and vascular causes
   
−
== Management ==
+
==Management==
   
−
* Determine cause
+
*Determine cause
−
* Consider high-dose steroids 1g/d x3-5 days
+
*Consider high-dose steroids 1g/d x3-5 days
−
* Thromboembolism prophylaxis
+
*Thromboembolism prophylaxis
−
* Symptom management for pain and spasticity
+
*Symptom management for pain and spasticity
−
** Muscle relaxants
+
**Muscle relaxants
−
* Rehab (PT/OT)
+
*Rehab (PT/OT)
−
* Follow-up investigations
+
*Follow-up investigations
−
** Repeat MRI
+
**Repeat MRI
   
 
[[Category:Neurology]]
 
[[Category:Neurology]]

Revision as of 10:18, 29 July 2020

Definition

  • Heterogeneous condition characterized by inflammation of the spinal cord

Etiology

Clinical Manifestations

  • Presentation is either acute or subacute, usually starting with sensory changes, weakness, or pain
  • Characterized by both motor and sensory deficits, with specific deficits depending on the spinal level of the lesion

Investigations

  • MRI spine with gadolinium, showing characteristic T2 hyperintensity without evidence of cord compression
  • CSF showing pleocytosis

Diagnosis

  • Sensorimotor and autonomic spinal cord dysfunction
    • Generally bilateral but may be asymmetric
  • Clearly defined sensory level
  • Bilateral signs and symptoms
  • Progression peaking between 4h and 21d after onset
  • Demonstration of spinal cord inflammation
    • Cerebrospinal fluid with pleocytosis or increased IGG
    • MRI with gadolinium
  • Exclusion of compressive, postradiation, neoplastic, and vascular causes

Management

  • Determine cause
  • Consider high-dose steroids 1g/d x3-5 days
  • Thromboembolism prophylaxis
  • Symptom management for pain and spasticity
    • Muscle relaxants
  • Rehab (PT/OT)
  • Follow-up investigations
    • Repeat MRI